Gland Pharma To Invest ₹175 crore In US Subsidiary, Aims For Business Expansion
By Sohail Khan · 1 Oct
Gland Pharma will invest USD 21 million (approximately ₹175 crore) in its wholly-owned US subsidiary, Gland Pharma USA Inc., to facilitate business expansion in the United States. The company also announced leadership changes with one director resigning and another appointed. Add As a Trusted Source






















